SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-379131
Filing Date
2013-09-26
Accepted
2013-09-26 07:02:06
Documents
8
Period of Report
2013-09-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d603690d8k.htm 8-K 18549
2 EX-1.1 d603690dex11.htm EX-1.1 150192
3 EX-5.1 d603690dex51.htm EX-5.1 7258
4 EX-99.1 d603690dex991.htm EX-99.1 3499
5 EX-99.2 d603690dex992.htm EX-99.2 7935
6 GRAPHIC g6036901.jpg GRAPHIC 14610
7 GRAPHIC g603690g40b29.jpg GRAPHIC 3475
8 GRAPHIC g603690image-005.jpg GRAPHIC 11037
  Complete submission text file 0001193125-13-379131.txt   229143
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 131115574
SIC: 2834 Pharmaceutical Preparations